Malik Khurram Khan, MD FCCP

Pulmonary and Critical care, Associate Professor @UK_Healthcare. COPD/Pulmonary rehab/Medical Education. Tweets represent personal opinions and biases.

[CHEST @accpchest]

Emerging diagnostic algorithms and advances in therapy could transform management of alpha-1 antitrypsin deficiency. Hear more from Malik Khurram Khan, MD, FCCP, in #CHEST2026: Inside Look: https://t.co/O4uwSqhKX5

[ERS publications @ERSpublications]

Eur Respir J: Alvelestat, an oral neutrophil elastase (NE) inhibitor, demonstrated a favourable safety profile, suppressed NE and improved disease activity biomarkers when taken at 240 mg twice daily for 12 weeks in severe alpha-1 antitrypsin deficiency https://t.co/LTZEC7APKl

[American Thoracic Society (ATS) @atscommunity]

Today is #WorldCOPDDay! In recognition of World COPD Day on Nov. 19, @FIRS_LungsFirst, of which the ATS is a founding member, is highlighting the importance of correctly diagnosing COPD earlier, with the theme “Short of Breath, Think COPD.”  

Learn more: https://t.co/tWLm9rCO9p

[CHEST @accpchest]

Pulmonary rehabilitation is a cornerstone in managing chronic lung disease—but how can the United States better meet the growing need? 🔗 Read more in CHEST Physician: https://t.co/DOS7aucdi7

[Malik Khurram Khan, MD FCCP @khurramsherkhan]

Was an honor to share the stage with these experts. Thank you ⁦@OPourshahid⁩, Dr. Rochester and Dr. Bourbeau. ⁦@accpchest⁩ #CHEST2025 ⁦@CHEST_ILDTx⁩ ⁦@UKYMedicine⁩

[Malik Khurram Khan, MD FCCP @khurramsherkhan]

Is it time for virtual pulmonary rehabilitation? Is more personalization the answer we are looking for? Come join us for a Pro-Con Debate as experts debate each other on Tuesday at 8 am. #CHEST2025 #ChestSoMe ⁦@accpchest⁩

[Malik Khurram Khan, MD FCCP @khurramsherkhan]

@fzebaMD @accpchest Congrats!! You thoroughly deserve this!!!

[Nicola A. Hanania @Hananianick]

Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization | NEJM Evidence https://t.co/8VbWmrlS0f

[UK HealthCare @UK_HealthCare]

Our UK Pulmonary Rehabilitation team includes physical and respiratory therapists, an exercise physiologist, and a nurse. Our team will work with you on breathing retraining and strategies for managing breathing problems.

Learn more 👇
https://t.co/htSgORbT2u

[PR Assembly @PR_Assembly]

HAPPY PULMONARY REHAB WEEK! March 9-15!

[American Thoracic Society (ATS) @atscommunity]

It's National Pulmonary Rehabilitation (PR) Awareness Week! PR improves breathlessness, physical function, & quality of life better than any other therapy.

[The Lancet Respiratory Medicine @LancetRespirMed]

Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial

Read open access here: https://t.co/WJ9R052uiF

@MonaBafadhel @BTSrespiratory @SanjayResp
@kingsmedicine

[Pulmonary Rehab Awareness @pulmonaryrehab@bsky) @prwukee]

#pulmonaryrehab
#pulmonaryrehabilitation

"The most underused drug in the history of medicine"

#WorldCOPDDay

[Malik Khurram Khan, MD FCCP @khurramsherkhan]

@CKressinPharmD @KatSpazPharmD Congrats!!

[Malik Khurram Khan, MD FCCP @khurramsherkhan]

Please join us for our session on pulmonary rehabilitation in chronic lung diseases and its challenges and the future of tele rehabilitation.@accpchest @CHEST_ILDTx @UKYMedicine #CHEST2024

[Healio Pulmonology @HealioPulm]

🚨FDA NEWS🚨
The #FDA has granted approval to #dupilumab (#Dupixent; @Regeneron, @sanofi) for treating adults with poorly controlled #COPD with type 2 #inflammation, according to a manufacturer-issued press release.

Read more⬇️ https://t.co/cS8oTIX58j

[Malik Khurram Khan, MD FCCP @khurramsherkhan]

@AdrishMD @accpchest @BCM_Lung @BCMDeptMedicine @CHESTAirways Congratulations!! Well deserved

[Malik Khurram Khan, MD FCCP @khurramsherkhan]

@emily_fri @ERSpublications @UK_HealthCare @ukypccm Thank you !!

[Malik Khurram Khan, MD FCCP @khurramsherkhan]

Honored to be a part of this! #copd
@ERSpublications @UK_HealthCare
@ukypccm

[ERS publications @ERSpublications]

Our understanding of COPD, including how it can be defined, how it progresses and how it might be prevented, continues to evolve @ijlalk5 @khurramsherkhan @dmmannino https://t.co/ESrxORdNdS

[ERS publications @ERSpublications]

The ERS Monograph on COPD in the 21st Century is out now. This Monograph provides an up-to-date overview of what is happening in this exciting field, both at a basic and a clinical level. https://t.co/WcxIiKyZ0M